• Je něco špatně v tomto záznamu ?

Blood pressure in children with renal cysts and diabetes syndrome

T. Seeman, F. Weigel, K. Blahova, F. Fencl, S. Pruhova, K. Hermes, R. Klaus, B. Lange-Sperandio, V. Grote, U. John-Kroegel

. 2021 ; 180 (12) : 3599-3603. [pub] 20210626

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22003089
E-zdroje Online Plný text

NLK ProQuest Central od 1996-01-01 do Před 1 rokem
CINAHL Plus with Full Text (EBSCOhost) od 2012-01-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1997-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 1996-01-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1996-01-01 do Před 1 rokem
Family Health Database (ProQuest) od 1996-01-01 do Před 1 rokem
Public Health Database (ProQuest) od 1996-01-01 do Před 1 rokem

Odkazy

PubMed 34176013
DOI 10.1007/s00431-021-04165-1
Knihovny.cz E-zdroje

Cystic kidney diseases such as autosomal recessive or dominant polycystic kidney disease (ARPKD and ADPKD) are associated with high prevalence of arterial hypertension. On the contrary, studies on hypertension in children with renal cysts and diabetes (RCAD) syndrome caused by abnormalities in the HNF1B gene are rare. Therefore, the primary aim of our study was to investigate the prevalence of high blood pressure in children with RCAD syndrome due to HNF1B gene abnormalities and secondary to search for possible risk factors for development of high blood pressure. Data on all children with genetically proven RCAD syndrome from three pediatric nephrology tertiary centers were retrospectively reviewed (office blood pressure (BP), ambulatory blood pressure monitoring (ABPM), creatinine clearance, renal ultrasound, echocardiography, albuminuria/proteinuria). High blood pressure was defined as BP ≥ 95th percentile of the current ESH 2016 guidelines and/or by the use of antihypertensive drugs. Thirty-two children with RCAD syndrome were investigated. Three children received ACE inhibitors for hypertension and/or proteinuria. High blood pressure was diagnosed using office BP in 22% of the children (n = 7). In the 7 performed ABPM, 1 child (14%) was diagnosed with hypertension and one child with white-coat hypertension. Creatinine clearance, proteinuria, albuminuria, body mass index, enlargement, or hypodysplasia of the kidneys and prevalence of HNF1B-gene deletion or mutation were not significantly different between hypertensive and normotensive children.Conclusion: High blood pressure is present in 22% of children with RCAD syndrome. What is Known: • Arterial hypertension is a common complication in children with polycystic kidney diseases. What is New: • High office blood pressure is present in 22% and ambulatory hypertension in 14% of children with renal cyst and diabetes (RCAD) syndrome.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003089
003      
CZ-PrNML
005      
20220127150702.0
007      
ta
008      
220113s2021 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00431-021-04165-1 $2 doi
035    __
$a (PubMed)34176013
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Seeman, Tomáš $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University Prague, Prague, Czech Republic. tomas.seeman@lfmotol.cuni.cz $u Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, Munich, Germany. tomas.seeman@lfmotol.cuni.cz
245    10
$a Blood pressure in children with renal cysts and diabetes syndrome / $c T. Seeman, F. Weigel, K. Blahova, F. Fencl, S. Pruhova, K. Hermes, R. Klaus, B. Lange-Sperandio, V. Grote, U. John-Kroegel
520    9_
$a Cystic kidney diseases such as autosomal recessive or dominant polycystic kidney disease (ARPKD and ADPKD) are associated with high prevalence of arterial hypertension. On the contrary, studies on hypertension in children with renal cysts and diabetes (RCAD) syndrome caused by abnormalities in the HNF1B gene are rare. Therefore, the primary aim of our study was to investigate the prevalence of high blood pressure in children with RCAD syndrome due to HNF1B gene abnormalities and secondary to search for possible risk factors for development of high blood pressure. Data on all children with genetically proven RCAD syndrome from three pediatric nephrology tertiary centers were retrospectively reviewed (office blood pressure (BP), ambulatory blood pressure monitoring (ABPM), creatinine clearance, renal ultrasound, echocardiography, albuminuria/proteinuria). High blood pressure was defined as BP ≥ 95th percentile of the current ESH 2016 guidelines and/or by the use of antihypertensive drugs. Thirty-two children with RCAD syndrome were investigated. Three children received ACE inhibitors for hypertension and/or proteinuria. High blood pressure was diagnosed using office BP in 22% of the children (n = 7). In the 7 performed ABPM, 1 child (14%) was diagnosed with hypertension and one child with white-coat hypertension. Creatinine clearance, proteinuria, albuminuria, body mass index, enlargement, or hypodysplasia of the kidneys and prevalence of HNF1B-gene deletion or mutation were not significantly different between hypertensive and normotensive children.Conclusion: High blood pressure is present in 22% of children with RCAD syndrome. What is Known: • Arterial hypertension is a common complication in children with polycystic kidney diseases. What is New: • High office blood pressure is present in 22% and ambulatory hypertension in 14% of children with renal cyst and diabetes (RCAD) syndrome.
650    _2
$a krevní tlak $7 D001794
650    _2
$a ambulantní monitorování krevního tlaku $7 D018660
650    _2
$a nemoci centrálního nervového systému $7 D002493
650    _2
$a dítě $7 D002648
650    _2
$a zubní sklovina $x abnormality $7 D003743
650    12
$a diabetes mellitus $7 D003920
650    _2
$a diabetes mellitus 2. typu $7 D003924
650    _2
$a lidé $7 D006801
650    12
$a hypertenze $x epidemiologie $x etiologie $7 D006973
650    _2
$a cystická onemocnění ledvin $7 D052177
650    12
$a polycystické ledviny autozomálně dominantní $7 D016891
650    _2
$a retrospektivní studie $7 D012189
655    _2
$a časopisecké články $7 D016428
700    1_
$a Weigel, Friederike $u Department of Pediatrics, Friedrich-Schiller-University Jena, Jena, Germany
700    1_
$a Blahova, Kveta $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University Prague, Prague, Czech Republic
700    1_
$a Fencl, Filip $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University Prague, Prague, Czech Republic
700    1_
$a Pruhova, Stepanka $u Department of Pediatrics, 2nd Faculty of Medicine, Charles University Prague, Prague, Czech Republic
700    1_
$a Hermes, Katharina $u Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, Munich, Germany
700    1_
$a Klaus, Richard $u Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, Munich, Germany
700    1_
$a Lange-Sperandio, Bärbel $u Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, Munich, Germany
700    1_
$a Grote, Veit $u Department of Pediatrics, Dr. von Hauner Children´s Hospital, University Hospital, LMU Munich, Munich, Germany
700    1_
$a John-Kroegel, Ulrike $u Department of Pediatrics, Friedrich-Schiller-University Jena, Jena, Germany
773    0_
$w MED00009638 $t European journal of pediatrics $x 1432-1076 $g Roč. 180, č. 12 (2021), s. 3599-3603
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34176013 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127150658 $b ABA008
999    __
$a ok $b bmc $g 1750757 $s 1154238
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 180 $c 12 $d 3599-3603 $e 20210626 $i 1432-1076 $m European journal of pediatrics $n Eur J Pediatr $x MED00009638
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace